Head to Head Review: Inhibikase Therapeutics (NYSE:IKT) and Senti Biosciences (NASDAQ:SNTI)
Senti Biosciences (NASDAQ:SNTI – Get Free Report) and Inhibikase Therapeutics (NYSE:IKT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability. Risk and Volatility Senti Biosciences has a […]
More Stories
Pentagon Identifies 6 Airmen Killed in Refueling Plane Crash in Iraq
By Ryan Morgan The Pentagon has identified the six Airmen who were killed after their KC-135 Stratotanker aerial refueling aircraft...
US Urges Americans to Leave Iraq Immediately
By Jacki Thrapp The U.S. Embassy in Baghdad urged all American citizens to leave Iraq immediately on March 14. “U.S....
US Flag Raised Over Embassy in Venezuela for First Time in 7 Years
By Ryan Morgan The U.S. flag flew over the U.S. Embassy in the Venezuelan capital city of Caracas for the...
Wall Street Review: Stocks Continue Sell-Off on Soaring Oil
By Panos Mourdoukoutas Wall Street stocks closed lower for a third consecutive week as rising oil prices, higher bond yields,...
Court Blocks Subpoenas Tied to Criminal Probe of Fed Chair Jerome Powell
By Andrew Moran A federal judge blocked subpoenas issued to the Federal Reserve as part of a criminal investigation of...
Jeffrey Epstein Guard Called to Testify Before House Oversight Committee
By Jacki Thrapp One of the guards on duty when Jeffrey Epstein died in his cell will testify before the...